PATENT CLAIM ANALYSIS

Application Number: 16110646
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "006110"]

Abstract:
The invention provides methods, devices, compositions and kits for diagnosing or predicting transplant status or outcome in a subject who has received a transplant.

Claim (Index 15):
The method of  claim 1 , wherein said circulating cell-free deoxyribonucleic acid is provided from plasma.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.17391
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16110682', '13508318', '14188455', '14536300', '15319271']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.664545468673161
- 35 USC 102 Novelty (BERT): 0.5548550085485793
- Combined Prediction Score: 0.6535764226607028
- Mean Citation Score: 336.547818
- Max Citation Score: 442.75372
- Similarity Product: 342.24305807688467

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test